Executed a thorough change in commercial organisation and culture, pursued an operational turnaround in its key sites and gained access to the attractive pharma segment through a targeted add-on. The company claimed back its leading position in the market globally, more than doubling profits.

Situation

Underperforming and succession issue

Business

Manufacturing and assembly of dispensing solutions serving predominantly global blue-chip customers in personal care and pharma